Healthcare provider profile · identity verified

Todd E Baldwin, DO

Family Practice · LAKE KATRINE, NY · NPI 1275537250

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	487	136
Amlodipine Besylate	Amlodipine Besylate	294	87
Lisinopril	Lisinopril	255	73
Levothyroxine Sodium	Levothyroxine Sodium	234	63
Simvastatin	Simvastatin	195	50
Omeprazole	Omeprazole	194	54
Losartan Potassium	Losartan Potassium	180	52
Metoprolol Succinate	Metoprolol Succinate	166	50
Metformin Hcl	Metformin Hcl	122	37
Hydrochlorothiazide	Hydrochlorothiazide	119	38
Lorazepam	Lorazepam	110	33
Montelukast Sodium	Montelukast Sodium	106	26
Escitalopram Oxalate	Escitalopram Oxalate	105	28
Rosuvastatin Calcium	Rosuvastatin Calcium	105	33
Gabapentin	Gabapentin	100	39
Zolpidem Tartrate	Zolpidem Tartrate	100	14
Albuterol Sulfate Hfa	Albuterol Sulfate	88	34
Tamsulosin Hcl	Tamsulosin Hcl	79	27
Allopurinol	Allopurinol	78	18
Pantoprazole Sodium	Pantoprazole Sodium	78	23
Eliquis	Apixaban	69	18
Bupropion Xl	Bupropion Hcl	67	18
Metformin Hcl Er	Metformin Hcl	65	21
Metoprolol Tartrate	Metoprolol Tartrate	62	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	14
Ozempic	Semaglutide	57	suppressed
Meloxicam	Meloxicam	51	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	16
Sertraline Hcl	Sertraline Hcl	47	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	11
Pravastatin Sodium	Pravastatin Sodium	45	13
Alprazolam	Alprazolam	44	24
Glimepiride	Glimepiride	44	15
Jardiance	Empagliflozin	43	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	42	suppressed
Valsartan	Valsartan	42	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	11
Warfarin Sodium	Warfarin Sodium	39	suppressed
Atenolol	Atenolol	38	12
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Synthroid	Levothyroxine Sodium	37	suppressed
Trazodone Hcl	Trazodone Hcl	37	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Ondansetron Odt	Ondansetron	36	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	13
Ramipril	Ramipril	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Carvedilol	Carvedilol	30	suppressed
Celecoxib	Celecoxib	30	suppressed
Furosemide	Furosemide	29	14
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Ibandronate Sodium	Ibandronate Sodium	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Prednisone	Prednisone	26	23
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Clonazepam	Clonazepam	22	suppressed
Finasteride	Finasteride	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Famotidine	Famotidine	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	15
Ibuprofen	Ibuprofen	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Diazepam	Diazepam	14	suppressed
Epinastine Hcl	Epinastine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Glipizide	Glipizide	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Potassium Chloride	Potassium Chloride	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Minocycline Hcl	Minocycline Hcl	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error